Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers

Journal of Clinical Pharmacology

Volumn 40, Issue 11, 2000, Pages 1227-1236

  Affrime, M B ^a   Cuss, F ^a   Padhi, D ^a   Wirth, M ^a   Pai, S ^a   Clement, R P ^a   Lim, J ^a   Kantesaria, B ^a   Alton, K ^a   Cayen, M N ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MOMETASONE FUROATE; PLACEBO; TRITIUM;

ADULT; ARTICLE; ASTHMA; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRY POWDER; FEMALE; HUMAN; MALE; METERED DOSE INHALER; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY;

ABSORPTION; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; POWDERS; PREGNADIENEDIOLS;

EID: 0033753118     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Relative safety and efficacy of inhaled corticosteroids
2. Effect of inhaled corticosteroids on bones and growth
3. Clinical aspects of anti-inflammatory therapy in asthma
4. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
5. The British guidelines on asthma management 1995 review and position statement
6. The meaning of lung dose
7. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI
8. Pharmacokinetics and pharmacodynamics of fluticasone propionate: Possible HPA-axis suppression during asthma treatment
9. Topical mometasone: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
10. Mometasone furoate: A review of its intranasal use in allergic rhinitis
11. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
12. Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis
13. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group
14. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis
15. Efficacy and safety of inhaled corticosteroids: New developments
16. The human pharmacology of fluticasone propionate
17. Rectal pharmacokinetics of budesonide
18. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects
19. Pharmacokinetics of triamcinolone acetonide and its phosphate ester
20. Reversible fatty acid conjugation of budesonide: Novel mechanism for prolonged retention of topically applied Steroid in airway tissue
21. Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes
22. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
23. Dose-response of inhaled drugs in asthma: An update
24. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers